Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Birchview Capital’

Pressmaster/Shutterstock.com

13D Filing: Birchview Capital and Yield10 Bioscience Inc. (YTEN)

Yield10 Bioscience Inc. (NASDAQ:YTEN): Matthew Strobeck’s Birchview Capital filed an amended 13D. You can check out Birchview Capital’s latest......(read more)
biotech research company, bio-technology companies

13G Filing: Birchview Capital and Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (NASDAQ:SLNO): Matthew Strobeck’s Birchview Capital filed an amended 13D. You can check out Birchview Capital’s latest......(read more)
Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG), Accelerate Diagnostics Inc (AXDX) and Metabolix, Inc. (MBLX) Among Birchview’s Top Bioscience Picks

Dr. Matthew Strobeck‘s Birchview Capital has recently disclosed its equity holdings in a 13F filing with the SEC. The market value of the fund&#......(read more)